The roles and limitations of bevacizumab in the treatment of ovarian cancer-Reference-Cited by-同舟云学术

The roles and limitations of bevacizumab in the treatment of ovarian cancer

Published:2022-04-27 Issue:7 Volume:27 Page:1120-1126
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Nakai Hidekatsu,Matsumura Noriomi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-022-02169-x.pdf

Reference36 articles.

1. Burger RA, Brady MF, Bookman MA et al (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365:2473–2783

2. Perren TJ, Swart AM, Pfisterer J et al (2011) A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med 365:2484–2496

3. Nakai H, Matsumura N (2022) Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs. Int J Clin Oncol. https://doi.org/10.1007/s10147-022-02163-3 (Online ahead of print)

4. NCCN Clinical Practice Guidelines in Oncology; Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer (2021) Version 3. https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf

5. Bais C, Mueller B, Brady MF et al (2017) Tumor microvessel density as a potential predictive marker for bevacizumab benefit: GOG-0218 biomarker analyses. J Natl Cancer Inst 109:djx066

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment;Future Pharmacology;2024-09-12

2. Drug resistance in human cancers — Mechanisms and implications;Life Sciences;2024-09

3. Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study;British Journal of Cancer;2024-08-30

4. Aberrant angiogenic signaling pathways: Accomplices in ovarian cancer progression and treatment;Cellular Signalling;2024-08

5. Ovarian cancer: Diagnosis and treatment strategies (Review);Oncology Letters;2024-07-18